Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company BioLineRx Ltd.
DescriptionFormulation of undisclosed components approved for non-surgical removal of benign skin lesions delivered using a pen-like applicator
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentPhase I/II
Standard IndicationScars / wrinkles
Indication DetailsTreat seborrheic keratosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today